MEN 2 syndromes (caused by a mutation in the RET protooncogene), in particular, warrant evaluation of associated pathologies such as medullary thyroid carcinoma and hyperparathyroidism [7]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.